{
    "nctId": "NCT04638751",
    "briefTitle": "ARGONAUT: Stool and Blood Sample Bank for Cancer Patients",
    "officialTitle": "ARGONAUT: Development and Analysis of a Blood and Stool Sample Bank for Cancer Patients, Enabling the Systematic Study of the Effect of Gut Microbiomes on Response to Treatment",
    "overallStatus": "RECRUITING",
    "conditions": "Non-small Cell Lung Cancer, Colorectal Cancer, Triple Negative Breast Cancer, Pancreas Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 5000,
    "primaryOutcomeMeasure": "Determine whether the microbiome composition can predict progression-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Men or women who are \u2265 18 years old with stage III or stage IV non-small cell lung cancer (NSCLC), colorectal cancer, triple-negative breast cancer, or pancreatic cancer treated by a particular cancer treatment for the first time, OR healthy subjects undergoing a standard of care colonoscopy\n* Subjects able to provide written informed consent\n\nExclusion Criteria:\n\n* Subjects with known HIV, Hepatitis A, Hepatitis B, Hepatitis C, or SARS-CoV2\n* Subjects without the mental capacity to complete either a written or online questionnaire, alone or with assistance, or make sound decisions\n* Women who are pregnant or who plan on becoming pregnant\n* Women who are nursing",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}